Isomorphic Labs Secures $600M to Advance AI Drug Design
Isomorphic Labs, a spinout from DeepMind, has raised $600 million in its first external funding round. The round was led by Thrive Capital, with participation from Google Ventures and Alphabet. This funding aims to accelerate the development of Isomorphic Labs' AI drug design engine and advance its drug candidates to clinical trials by the end of the year.
The company, headquartered in London with an office in Lausanne, Switzerland, is focused on reducing the time required to discover new medicines. It leverages DeepMind's AlphaFold technology to predict protein interactions with other molecules, applying this to a broader range of biological molecules. Isomorphic Labs has partnered with pharmaceutical giants like Eli Lilly and Novartis and is primarily focused on oncology and immunology.
Demis Hassabis, founder and CEO of Isomorphic Labs, stated that the funding will enhance their AI research and development efforts and expand their team. The company has been on a rapid growth trajectory since its inception in 2021, having quadrupled its R&D spending in 2023.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales Platform Oct 15 Cohere Agrees to Acquire AI Security Startup AISLEMore from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessAI Funding Brief
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Linearis Joins Two Canadian AI Health Data Projects
Flagship Pioneering Launches Iris Labs With $20 Million
Danaher Plans AI Autonomous Lab for Antibody Research
XtalPi Launches Kodexia siRNA Discovery Platform
Daily AI Brief: the AI news that matters, in your inbox.